Date:         Tue, 17 Dec 2002 10:14:48 -0500
Reply-To:     "Fehd, Ronald J. (PHPPO)" <rjf2@CDC.GOV>
Sender:       "SAS(r) Discussion" <SAS-L@LISTSERV.UGA.EDU>
From:         "Fehd, Ronald J. (PHPPO)" <rjf2@CDC.GOV>
Subject:      Re: selection of records url: MedDRA
Comments: cc: "Schechter, Robert S" <robert.schechter@ASTRAZENECA.COM>,
          "wim.goettsch@PHARMO.NL" <wim.goettsch@PHARMO.NL>
Content-Type: text/plain

> -----Original Message-----
> From: Wim Goettsch [mailto:wim.goettsch@PHARMO.NL]

> From: Schechter, Robert S [mailto:robert.schechter@ASTRAZENECA.COM]

> Or is what you need something like MedDRA (the Medical
> Dictionary for Regulatory Activities), the new global
> standard medical terminology, which will soon supersede or
> replace terminologies currently in use with the medical
> product development process.

http://www.meddramsso.com/

> Major global regulatory authorities (within the US, Europe
> and Japan) are adopting MedDRA and moving toward requiring
> its use. The FDA,

http://www.fda.gov/medwatch/report/meddra.htm

> for example, has already implemented MedDRA
> within its Adverse Event Reporting System (AERS). European
> authorities are beginning to use MedDRA as a key part of
> their electronic database systems.